期刊名称：INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
About this journal
The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
Related subjects » Internal Medicine - Oncology & Hematology - Pathology - Radiology
Abstracted/Indexed in:abstracted_indexed
Abstracts in Anthropology, Academic OneFile, Academic Search, Chemical Abstracts Service (CAS), Current Abstracts, EMBASE, Gale, Google Scholar, Health Reference Center Academic, IBIDS, INIS Atomindex, INPHARMA, Journal Citation Reports/Science Edition, OCLC, PubMed/Medline, Science Citation Index Expanded (SciSearch), SCOPUS, Summon by Serial Solutions, TOC Premier
Aims and scope The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
Instructions to Authors
International Journal of Clinical Oncology
Manuscript submission
Legal requirements:
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Prerequisites for publication:
A copy of the certification form included in each issue must be submitted to the journal’s editorial office by fax (+81-3-6831-7010) at the same time you submit your manuscripts via Manuscript Central.
IMPORTANT: Upon receipt of a Certificate of Exclusive Submission, manuscripts are officially recognized as submissions. The editorial board decides whether to accept or reject submitted manuscripts in consultation with at least two referees.
Permissions:
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online submission:
Authors should submit their manuscripts to the International Journal of Clinical Oncology online. No manuscripts will be accepted by mail or fax. Please log in directly at: http://mc.manuscriptcentral.com/ijco and upload your manuscript following the instructions given. In case you encounter any difficulties while submitting your manuscript online, click on the Get Help Now in the upper right corner.
Potential conflict of interest
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. They should also state that they have full control of all primary data and that they agree to allow the journal to review their data if requested.
Therefore the manuscript must be accompanied by the "Conflict of Interest Disclosure Statement". This form can be obtained from http://www.springer.com/journal/10147/.
Manuscript preparation
Types of articles:
Articles may be in the form of original articles, case reports, letters to the editor, review articles, and editorials.
- Original articles should not exceed 3000 words, not including the abstract, references, tables, and figure captions. The text should be arranged in accordance with the format described below in “Text”. Acceptance of an original article is based primarily on the originality of the work and its potential clinical influence. For reports of randomized controlled trials, authors should refer to the CONSORT statement of guidelines (http://www.consort-statement.org). For studies of the diagnostic accuracy of tests, authors are encouraged to refer to the STARD statement (http://www.stard-statement.org/).
- Case reports should describe new observations of diseases, clinical findings, or novel/unique treatment outcomes relevant to practicing oncologists, and should be presented as concisely as possible, not to exceed 1500 words, and references should be kept to a minimum. A pathologist should be included as an author if the report describes significant histological findings. Only case reports with new findings that have significant clinical impact on the field of oncology or that are likely to change clinical practice, methods, or approaches will be accepted for publication. Authors should avoid the following: describing rare cases or conditions without adding new findings; describing a combination of different tumors without providing new information; or describing the outstanding impact of an existing clinical practice without providing an explanation of its efficacy. Case reports in which the patient’s diagnosis remains uncertain following initial treatment will not be considered for publication.
- Letters to the editor may offer criticism of published material. They must be objective, constructive, and educational, and should not exceed 500 words, not including references, tables, and figure captions.
- Review articles provide an overview of the state of the art in an area or an update in areas of current interest in clinical oncology. Review articles are solicited by the editors.
- Editorials may be published as viewpoints of the editor(s) of the journal on current, relevant topics.
Manuscript form:
The abstract, text, references, tables, and figure captions must be typed double-space with wide margins. Incomplete or improperly prepared manuscripts will be returned to the authors without review. A separate cover page should be provided. The abstract, text, acknowledgments, references, tables, captions, and figures should begin on separate sheets and follow in that order. Standard abbreviations and units should be used. Abbreviations should be defined at first appearance, and their use in the title and abstract should be avoided. Generic names of drugs and chemicals should be used.
All manuscripts must be written in English. Authors who are not fluent in English must seek the assistance of a colleague who is a native English speaker and is familiar with the field of the work.
Cover page:
The cover page should contain the title, the full names of the authors, and the street address of the authors’ academic affiliations. Please supply a fax number, telephone number, and e-mail address for the proofs.
Abstract and mini-abstract:
The abstract should be comprehensible without reference to the text, and the use of abbreviations should be avoided whenever possible. The abstract should not exceed 250 words and should be arranged under the following subheadings for original articles: (1) Background (the problem being addressed and the purpose of the study); (2) Methods (study design/methods and materials); (3) Results (research findings), and (4) Conclusion(s) (summary of the main findings obtained and the conclusions drawn). In addition, a mini-abstract summarizing within 30 words the significant conclusion of the study should be submitted, to appear in the table of contents. Save the mini-abstract in a separate file.
Key words:
3-6 key words should be listed below the abstract and mini-abstract.
Text:
The text should be arranged as follows: (1) Introduction; (2) Patients and methods, or Materials and methods; (3) Results; (4) Discussion; (5) Acknowledgment(s). The sections should describe: (1) the problem being addressed and the purpose of the study with reference to previous findings; (2) materials and methods used in the study in concise yet sufficient detail to allow the study to be replicated; (3) main findings obtained; (4) conclusions drawn from the findings and implications for further research and clinical application, with a review of relevant published literature and other evidence.
In Case reports, the abstract should be a brief summary of the contents without any subheadings. The text should be arranged as follows: (1) Abstract; (2) Introduction; (3) Case report; (4) Discussion.
Text formatting:
Manuscripts should be submitted in Word.
• Use a normal, plain font (e.g., 10-point Times Roman) for text.
• Use italics for emphasis.
• Use the automatic page numbering function to number the pages.
• Do not use field functions.
• Use tab stops or other commands for indents, not the space bar.
• Use the table function, not spreadsheets, to make tables.
• Save your file in doc format. Do not submit docx files.
Footnotes:
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables. Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols. Always use footnotes instead of endnotes.
References
Citation:
Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1-3, 7].
Reference list:
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list. The entries in the list should be numbered consecutively. Give the names of the first three authors only, followed by “et al” if there are other coauthors.
| Journal article |
| 1. Smith J, Jones M Jr, Houghton L, et al (1999) Future of health insurance. N Engl J Med 965:325–329 |
| 2. Inoue T, Sue K, Nakano K, et al. (1991) A case report of long survival in a 17-year-old girl with gastric carcinoma treated by immunochemo-endocrine therapy (in Japanese). Shinyaku to Rinsho (New Med) 40:117–121 |
| Article by DOI |
| 3. Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med (in press). doi: 10.1007/s001090000086 |
| Book |
| 4. South J, Blass B (2001) The future of modern genomics. Blackwell, London |
| Book chapter |
| 5. Brown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York, pp230-257 |
| Online document |
| 6. Doe J (1999) Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available via DIALOG. http://www.rsc.org/dose/title of subordinate document. Accessed Jan 1999 |
| Dissertation |
| 7. Trent JW (1975) Experimental acute renal failure. Dissertation, University of California |
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see http://www.issn.org/2-22661-LTWAonline.php
Tables
• All tables are to be numbered using Arabic numerals.
• Tables should always be cited in text in consecutive numerical order.
• For each table, please supply a table caption (title) explaining the components of the table.
• Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
• Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
Figures
Electronic Figure Submission:
• Supply all figures electronically.
• Indicate what graphics program was used to create the artwork.
• For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MS Office files are also acceptable.
• Vector graphics containing fonts must have the fonts embedded in the files.
• Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.
Line art:
• Definition: Black and white graphic with no shading.
• Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
• All lines should be at least 0.1 mm (0.3 pt) wide.
• Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
• Vector graphics containing fonts must have the fonts embedded in the files
Halftone art:
• Definition: Photographs, drawings, or paintings with fine shading, etc.
• If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
• Halftones should have a minimum resolution of 300 dpi.
Combination art:
• Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
• Combination artwork should have a minimum resolution of 600 dpi.
Color art:
• Color art is free of charge for online publication.
• If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
• If the figures will be printed in black and white, do not refer to color in the captions.
• Color illustrations should be submitted as RGB (8 bits per channel).
Figure lettering:
• To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
• Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
• Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
• Avoid effects such as shading, outline letters, etc.
• Do not include titles or captions into your illustrations.
Figure numbering:
• All figures are to be numbered using Arabic numerals.
• Figures should always be cited in the text in consecutive numerical order.
• Figure parts should be denoted by lowercase letters (a, b, c, etc.). If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure legends and citations.
• If an appendix appears in your article/chapter and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures, "A1, A2, A3, etc." Figures in online appendices (Electronic supplementary Material) should, however, be numbered separately.
Figure captions:
• Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
• Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
• No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
• Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
• Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.
Figure placement and size:
• When preparing your figures, size figures to fit in the column width.
• Figures should be 39 mm, 84 mm, 129 mm, or 174 mm wide and not higher than 234 mm.
The publisher reserves the right to reduce or enlarge figures.
Permissions:
If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.
After acceptance
During the production phase the following issues need to be clarified and you will receive the article’s proofs.
Copyright transfer:
Authors will be asked to transfer copyright of the article to the Japan Society of Clinical Oncology. This will ensure the widest possible protection and dissemination of information under copyright laws.
Offprints:
Offprints can be ordered by the corresponding author.
Color illustrations:
Online publication of color illustrations is free of charge. For color in the print version, authors will be expected to make a contribution towards the extra costs. (152 000 JPY per article). Otherwise the figures will be printed in black and white. Please note that, in such cases, it is authors’ responsibility to prepare figures to be illustrative enough to convey the necessary information even after they are converted into black and white.
Proof reading:
The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor. After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.
Online First:
The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.
Editorial Office
The Editorial Office of the "International Journal of Clinical Oncology"
c/o Springer Japan,
No. 2 Funato Bldg. 1-11-11 Kudan-Kita, Chiyoda-ku, Tokyo, 102-0073, Japan.
Tel.: +81-3-6831-7009; Fax: +81-3-6831-7010;
e-mail: ijco@springer.jp
Instructions to Authors
instr_print_10147.080627.pdf
Editorial Board
EDITOR-IN-CHIEF EMERITUS
Kazue Ozawa, Professor Emeritus, Shiga University of Medical Science
Professor Emeritus, Kyoto University Graduate School of Medicine
EDITOR-IN-CHIEF
Ikuo Konishi, Professor, Kyoto University Graduate School of Medicine
Associate Editors
Yoichi Arai, Tohoku University Graduate School of Medicine
Shigeki Arii, Tokyo Medical and Dental University
Akihiko Gemma, Nippon Medical School
Tomonori Habuchi, Akita University Graduate School of Medicine
Seiki Hasegawa, Hyogo College of Medicine
Takehiro Inoue, Osaka University Graduate School of Medicine
Hirotaka Iwase, Graduate School of Medical Sciences, Kumamoto University
Toshiharu Kamura, Kurume University School of Medicine
Susumu Kanazawa, Okayama University Graduate School of Medicine
Tadaaki Kirita, Nara Medical University
Yutaka Kohgo, Asahikawa Medical College
Hideo Mugishima, Nihon University School of Medicine
Takashi Nakatsuka, Saitama Medical University
Yasumasa Nishimura, Kinki University School of Medicine
Masahiko Nishiyama, Saitama Medical University International Medical Center
Shinzaburo Noguchi, Osaka University Graduate School of Medicine
Masahisa Saikawa, National Cancer Center Hospital East
Yoshiharu Sakai, Kyoto University Graduate School of Medicine
Junichi Sakamoto, Nagoya University Graduate School of Medicine
Noriaki Sakuragi, Hokkaido University School of Medicine and Graduate School of Medicine
Soichiro Shibui, National Cancer Center Hospital
Tomotaka Sobue, National Cancer Center
Naoyuki Shigematsu, Keio University School of Medicine
Hiroyuki Tsuchiya, Kanazawa University Graduate School of Medical Science
Takanori Ueda, University of Fukui Faculty of Medical Sciences
Toshiaki Watanabe, Teikyo University, School of Medicine
Nobuo Yaegashi, Tohoku University Graduate School of Medicine
Akifumi Yamamoto, Saitama Medical University International Medical Center
Deputy Editors
Takashi Inamoto
Masaki Mandai
Yasushi Nagata
Osamu Ogawa
Kazuichi Okazaki
Yutaka Shimada
INTERNATIONAL ADVISORY BOARD
R. Ackermann, Urologischen Universitats Klinik, Heinrich-Heine University, Germany
Karen H. Antman, Boston University School of Medicine, USA
Mario Campanacci, Instituto Ortopedico Rizzoli, Universita? di Bologna, Italy
James D. Cox, Department of Radiation Oncology, University of Texas, MD Anderson Cancer Center, USA
Merrill J. Egorin, Division of Developmental Therapeutics, University of Maryland Cancer Center, USA
Isaiah J. Fidler, Department of Cell Biology, University of Texas, MD Anderson Cancer Center, USA
Kathleen M. Foley, Pain Service, Department of Neurology, Memorial Sloane-Kettering Cancer Center, USA
Emil J. Freireich, Adult Leukemia Research Program, University of Texas, MD Anderson Cancer Center, USA
Ronald B. Herberman, University of Pittsburgh Cancer Institute, USA
Jeremy R. Jass, Department of Pathology, McGill University, Canada
Guo-Liang Jiang, Fudan University Cancer Hospital, China
Soon-Beom Kang, Department of Obstetrics and Gynecology, Seoul National University Hospital, Korea
Chongwook Lee, Department of Urology, Seoul National University Hospital, Korea
Martin C. Mihm, Senior Dermatopathologist, Massachusetts General Hospital, USA
C. Paul Morrow, Gynecologic Oncology, University of Southern California School of Medicine, USA
Foad Nahai, Department of Plastic and Reconstructive Surgery, Emory University, USA
Steven Piantadosi, Samuel Oschin Comprehensive Cancer Center Institute, Cedars-Sinai Medical Center, USA
Carol L. Shields, Ocular Oncology Service, Wills Eye Hospital, USA
J. Rudiger Siewert, Chirurgischen Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Germany
David G.T. Thomas, Gough-Cooper Department of Neurological Surgery, Institute of Neurology, University of London, UK
P.A. Voute, Emma Kinderziekenhuis, Academic Medical Centre, The Netherlands
John Wong, Department of Surgery, The University of Hong Kong, Hong Kong, China
John Eu-Li Wong, National University of Singapore, Singapore
EDITORIAL BOARD
Keisuke Aiba
Yoichi Ajioka
Koichiro Akakura
Tetsuo Akimoto
Sadao Amano
Masashi Ando
Daisuke Aoki
Yoichi Aoki
Keishiro Aoyagi
Takayuki Asao
Takeshi Azuma
Hideo Baba
Ryuichiro Doi
Shin Egawa
Masashi Fujii
Masato Fujii
Takuma Fujii
Masaki Fujimura
Takashi Fukagai
Ichio Fukasawa
Tetsushi Fukushige
Takashi Fukutomi
Tomohisa Furuhata
Toru Hachisuga
Chikuma Hamada
Nobuyuki Hamajima
Masayuki Haniuda
Isao Hara
Kiyoshi Hasegawa
Masatoshi Hasegawa
Yasuhisa Hasegawa
Masahito Hatori
Kazushige Hayakawa
Nobuyuki Hayashi
Shoichi Hazama
Takahiro Higashi
Tomoro Hishiki
Masamichi Hiura
Eiso Hiyama
Keiko Hiyama
Shigeo Horie
Jun Horiguchi
Rie Horii
Hajime Hosoi
Tomohiko Ichikawa
Masahide Ikeguchi
Tsuneo Imai
Masahiro Imamura
Shigeru Imoto
Takanori Ishida
Shigeto Ishidoya
Tetsuro Ishikawa
Chikashi Ishioka
Naoki Ishizuka
Jun Itami
Kazuto Ito
Kyogo Itoh
Hiromichi Iwasaki
Hiroji Iwata
Toshiko Jobo
Yoshikazu Kagami
Yoshihiro Kakeji
Tsunehisa Kaku
Nobuyuki Kamata
Toshiyuki Kamoto
Hiro-omi Kanayama
Katsuyuki Karasawa
Hidetaka Katabuchi
Hidenori Kato
Akira Kawai
Junzo Kigawa
Fumitaka Kikkawa
Go Kimura
Shinya Kimura
Hidefumi Kinoshita
Kensuke Kiyokawa
Masahiro Kizaki
Hiroaki Kobayashi
Hiroshi Kobayashi
Michiya Kobayashi
Yoichi Kobayashi
Takeshi Kodaira
Mikihiko Kogo
Shunji Kohnoe
Nobuo Koinuma
Masahiko Koizumi
Yukihiro Kondo
Keiichi Kubota
Jun-ichi Kuratsu
Kentaro Kuroiwa
Masato Kusunoki
Hiroyuki Kuwano
Taira Maekawa
Atsushi Makimoto
Naoya Masumori
Akio Matsubara
Takuya Matsunaga
Keitaro Matsuo
Hideyasu Matsuyama
Chikao Miki
Tetsuya Mitsudomi
Michihide Mitsumori
Ikuo Miura
Yoshiki Miyachi
Etsuko Miyagi
Kohji Miyazaki
Takashi Mizowaki
Masaki Mori
Masaru Morita
Satoshi Morita
Takuya Moriya
Hirofumi Mukai
Motoo Nagane
Masayuki Nakagawa
Hisayoshi Nakajima
Katsumasa Nakamura
Seigo Nakamura
Bunzo Nakata
Takeo Nakayama
Tomoki Naoe
Atsushi Nashimoto
Yasutomo Nasu
Kenji Nemoto
Ken-ichi Nibu
Miyuki Niimi
Nozomi Niitsu
Reiki Nishimura
Kazuto Nishio
Hiroyuki Nishiyama
Kinji Nishiyama
Tsutomu Nishiyama
Atsushi Ochiai
Kazunori Ochiai
Masahiko Oguchi
Michinori Ogura
Kazunori Ohnishi
Hitoshi Ohno
Shinji Ohno
Makoto Ohori
Shozo Ohsumi
Chikara Ohyama
Toshiro Okazaki
Toshikatsu Okumura
Hiroshi Onishi
Hisashi Onodera
Mototsugu Oya
Toshifumi Ozaki
Toshiaki Saeki
Satoru Sagae
Yoshiro Saikawa
Seiichi Saito
Toshiaki Saito
Tsuyoshi Saito
Shigehira Saji
Yoshihisa Sakaguchi
Akio Sakamoto
Kenshi Sakayama
Minoru Sakuraba
Hideki Sakurai
Rhohei Sasaki
Naoto Shikama
Mitsuo Shimada
Chikako Shimizu
Naohito Shimoyama
Nobuo Shinohara
Toshinori Soejima
Makoto Sugaya
Kenji Sugio
Kazuhiko Sugiyama
Toru Sugiyama
Kazuhiro Suzuki
Shigehiko Suzuki
Tatsuro Tajiri
Jun Takahashi
Satoru Takahashi
Akifumi Takaori-Kondo
Minoru Takata
Yoichi Takaue
Tetsuji Takayama
Seiichi Takenoshita
Izumi Takeyoshi
Kazuo Tamura
Akira Tangoku
Yusuke Tanigawara
Mitsune Tanimoto
Masanori Terashima
Fumitoshi Terauchi
Teruki Teshima
Kensei Tobinai
Junya Toguchida
Yasushi Toh
Takafumi Toita
Yoshihiro Torimoto
Tatsuya Toyama
Norihiko Tsuchiya
Hitoshi Tsuda
Shunichi Tsujitani
Yosuke Uchitomi
Takayuki Ueno
Hiroyuki Uetake
Hisashi Uhara
Shinobu Umemura
Takashi Uno
Masahiro Urade
Kimio Ushijima
Noriko Usui
Narikazu Uzawa
Takuro Wada
Yoh Watanabe
Hidemichi Watari
Jiro Watari
Yoshihiro Yakushijin
Kaichiro Yamamoto
Masakazu Yamamoto
Seiichiro Yamamoto
Tetsuji Yamamoto
Hideaki Yamana
Takahiro Yamauchi
Katsunari Yane
Kenji Yano
Atsunori Yorozu
Kazuhiro Yoshida
Hiroyuki Yoshikawa
Toshiki Yoshimine
Ichiro Yoshino
Takayuki Yoshino
Yasuo Yoshioka
|
